Indication
Details coming soon
Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Adult |
Dose: Not approved for adult. Note: Not approved for adult. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Prevention of invasive disease caused by Haemophilus influenzae type b Age: Pediatric (2, 4, and 6 months of age) |
Dose: Intramuscular Injection – 0.5 mL Frequency: Three doses total (one dose each at 2, 4, and 6 months) Note: Primary series. The first dose may be given as early as 6 weeks of age. |
|
Indication: Prevention of invasive disease caused by Haemophilus influenzae type b Age: Pediatric (15 through 18 months of age) |
Dose: Intramuscular Injection – 0.5 mL Frequency: once daily Note: Booster dose. |
Administration
- Give intramuscularly
- Inject in thigh or deltoid
Side Effect
- Irritability (72.6%)
- drowsiness (57.5%)
- tenderness (46.3%)
- induration (22.5%)
- fever (20.1%)
- anorexia (15.3%)
- diarrhea (4.4%)
- Pain
- Sleepiness
- Rash
- Vomiting
- Injection site erythema/induration/pain/soreness/warmth/swelling
- Otitis media
- URI
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Immunosuppressive therapies (irradiation, Antimetabolites (Methotrexate, Fluorouracil, Mercaptopurine)s, Alkylating Agents (Cyclophosphamide, Busulfan, Melphalan), cytotoxic drugs, Corticosteroids (Prednisone, Prednisolone, Methylprednisolone, Dexamethasone, Hydrocortisone) used in greater than physiologic doses)
|
May reduce the immune response to vaccine
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Data not available
|
Data not available
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
This vaccine has a shelf life of 2 years provided that the packaging is integral and the product correctly stored. Do not use the product after the expiry date. This vaccine should be stored and transported at a temperature between 2°C and +8°C.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.